Mason Street Advisors’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-3,592
| Closed | -$104K | – | 89 |
|
|
2020
Q4 | $104K | Sell |
3,592
-9
| -0.2% | -$261 | ﹤0.01% | 1484 |
|
|
2020
Q3 | $102K | Buy |
3,601
+37
| +1% | +$1.05K | ﹤0.01% | 1454 |
|
|
2020
Q2 | $115K | Buy |
3,564
+324
| +10% | +$10.5K | ﹤0.01% | 1436 |
|
|
2020
Q1 | $132K | Hold |
3,240
| – | – | ﹤0.01% | 1365 |
|
|
2019
Q4 | $200K | Buy |
3,240
+83
| +3% | +$5.12K | ﹤0.01% | 1383 |
|
|
2019
Q3 | $230K | Buy |
3,157
+344
| +12% | +$25.1K | ﹤0.01% | 1338 |
|
|
2019
Q2 | $231K | Buy |
2,813
+149
| +6% | +$12.2K | ﹤0.01% | 1331 |
|
|
2019
Q1 | $188K | Buy |
2,664
+89
| +3% | +$6.28K | ﹤0.01% | 1417 |
|
|
2018
Q4 | $116K | Buy |
2,575
+124
| +5% | +$5.59K | ﹤0.01% | 1433 |
|
|
2018
Q3 | $139K | Sell |
2,451
-170
| -6% | -$9.64K | ﹤0.01% | 1450 |
|
|
2018
Q2 | $175K | Buy |
2,621
+135
| +5% | +$9.01K | ﹤0.01% | 1406 |
|
|
2018
Q1 | $145K | Buy |
2,486
+155
| +7% | +$9.04K | ﹤0.01% | 1408 |
|
|
2017
Q4 | $150K | Buy |
2,331
+61
| +3% | +$3.93K | ﹤0.01% | 1398 |
|
|
2017
Q3 | $119K | Buy |
2,270
+290
| +15% | +$15.2K | ﹤0.01% | 1429 |
|
|
2017
Q2 | $93K | Buy |
1,980
+122
| +7% | +$5.73K | ﹤0.01% | 1456 |
|
|
2017
Q1 | $92K | Buy |
1,858
+112
| +6% | +$5.55K | ﹤0.01% | 1447 |
|
|
2016
Q4 | $106K | Buy |
1,746
+110
| +7% | +$6.68K | ﹤0.01% | 1420 |
|
|
2016
Q3 | $109K | Buy |
1,636
+153
| +10% | +$10.2K | ﹤0.01% | 1369 |
|
|
2016
Q2 | $83K | Buy |
1,483
+140
| +10% | +$7.84K | ﹤0.01% | 1394 |
|
|
2016
Q1 | $45K | Buy |
1,343
+121
| +10% | +$4.05K | ﹤0.01% | 1467 |
|
|
2015
Q4 | $55K | Buy |
1,222
+109
| +10% | +$4.91K | ﹤0.01% | 1422 |
|
|
2015
Q3 | $44K | Sell |
1,113
-22
| -2% | -$870 | ﹤0.01% | 1447 |
|
|
2015
Q2 | $70K | Buy |
1,135
+46
| +4% | +$2.84K | ﹤0.01% | 1388 |
|
|
2015
Q1 | $68K | Buy |
+1,089
| New | +$68K | ﹤0.01% | 1393 |
|